Article
Orlando, FL-Men with erectile dysfunction who fail initial treatment with sildenafil citrate (Viagra) are seeing varying degrees of improvement when therapy is supplemented with other agents, vacuum devices, or education and counseling.
Pivotal data for lumasiran in PH1 published in NEJM
Nedosiran explored in primary hyperoxaluria type 3
Enrollment completed in pivotal trial of nedosiran for hyperoxaluria
FDA approves androgen inhibitor for metastatic PCa
Blood test could guide treatment for kidney cancer
BCG for bladder cancer in short supply
FDA approves mitomycin intravesical solution for recurrent LG-IR-NMIBC
AI-based tool aims to optimize MRI use in prostate cancer diagnosis
PSMA-PET imaging product, Gozellix, launches on US market
Adding cetrelimab to niraparib maintenance shows benefit in aggressive variant prostate cancer